- Patent Title: Inhalable rapamycin formulation for treating age-related conditions
-
Application No.: US17301316Application Date: 2021-03-31
-
Publication No.: US11648199B2Publication Date: 2023-05-16
- Inventor: Thomas Armer , Lawrence S. Melvin, Jr. , Jonathan M. Rothberg , Henri Lichenstein
- Applicant: AI Therapeutics, Inc
- Applicant Address: US CT Guilford
- Assignee: Al Therapeutics, Inc.
- Current Assignee: Al Therapeutics, Inc.
- Current Assignee Address: US CT Guilford
- Agency: DLA Piper LLP (US)
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/72 ; A61K31/436 ; A61K9/00 ; A61K45/06 ; A61P11/00
Abstract:
The present invention relates to methods and compositions for anti-aging therapy and for the treatment and prophylaxis of age-related diseases and disorders in a human subject in need of such therapy or treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation, of composition comprising rapamycin, or a prodrug or derivative thereof.
Public/Granted literature
- US20210212942A1 INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS Public/Granted day:2021-07-15
Information query
